Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CTSU N0949 Principal Investigator: Wildes, Tanya
Title: Randomized Phase III Trial of mFOLFOX7 or XELOX Plus Bevacizumab Versus 5-Fluorouracil/Leucovorin or Capecitabine Plus Bevacizumab as First-line Treatment in Elderly Patients with Metastatic Colorectal Cancer
Phase: III Disease Site: Colon
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to compare the length of time during and after treatment that metastatic colorectal cancer does not get worse in older patients treated with bevacizumab plus either 5-fluorouracil/leucovorin or capecitabine without oxaliplatin or in patients treated with bevacizumab plus 5-fluorouracil/leucovorin or capecitabine with oxaliplatin.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)